Neovasc Plans ‘Two Shots On Goal’ For Reducer To Treat Angina

Neovasc’ COO Bill Little talked to Medtech Insight about the company’s plans to develop its Reducer transcatheter device to treat cardiac angina associated with or without obstructive coronary disease.